Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies.
Featured
Weekly Market Update: Stocks Flat as Energy Rises, Communication Services Fall
Eli Lilly Stock Is Up 18% This Year. Is It Still a Buy Ahead of Earnings?
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
Johnson & Johnson Earnings: Pharma Momentum, but MedTech Headwinds Dampen Growth
Latest Company Reports
- GMABGenmab AS
Positive Data for Rina-S and Petosemtamab Strengthen Narrow-Moat Genmab's Oncology Strategy
- Rating
- Price
- DKK 2,997.00
- Fair Value
- LOCK|c%
- Uncertainty
- LOCK|d!>k
- Economic Moat
- LOCK|>Jn>D
- Capital Allocation
- LOCK|%xc!kSd
- IPNIpsen SA
Narrow-Moat Ipsen's Diversified Growth Drivers Support Positive Outlook
- Rating
- Price
- €152.50
- Fair Value
- LOCK|hy
- Uncertainty
- LOCK|D?pW
- Economic Moat
- LOCK|n&hCv
- Capital Allocation
- LOCK|>Y<j%?
- GALDGalderma Group AG Registered Shares
Galderma's Diversified Dermatology Portfolio and Drug Pipeline Position It Well for Long-Term Growth
- Rating
- Price
- CHF 185.00
- Fair Value
- LOCK|@j
- Uncertainty
- LOCK|VQF#
- Economic Moat
- LOCK|>@WX
- Capital Allocation
- LOCK|<c@r!wR
- QGENQiagen NV
Qiagen Agrees to EUR 46.50/Share Buyout Offer From EQT
- Rating
- Price
- $50.17
- Fair Value
- Nsh
- Uncertainty
- LOCK|&y<&
- Economic Moat
- LOCK|&G@<
- Capital Allocation
- LOCK|y>FJ$p%
- RHHBYRoche Holding AG ADR
Roche's Lack of a Patent Cliff and Incremental Productivity Gains Support a Wide Moat
- Rating
- Price
- $60.37
- Fair Value
- $l
- Uncertainty
- LOCK|yw
- Economic Moat
- LOCK|nKX
- Capital Allocation
- LOCK|yF?Rfgn>
- RMDResMed Inc
ResMed Converts Physician Loyalty Into Pricing Power
- Rating
- Price
- $250.80
- Fair Value
- LOCK|FD
- Uncertainty
- LOCK|f^$Y!
- Economic Moat
- LOCK|HLQ^
- Capital Allocation
- LOCK|n#%SS%Ft
- ABTAbbott Laboratories
Abbott Seeks To Move Further Into Medtech by Shedding Nutrition Business
- Rating
- Price
- $103.10
- Fair Value
- LOCK|<!
- Uncertainty
- LOCK|kGX>
- Economic Moat
- LOCK|TvNv
- Capital Allocation
- LOCK|^#dVP>
- ELVElevance Health Inc
Elevance Continues To Aim for Margin Improvement, Despite Policy Headwinds
- Rating
- Price
- $421.49
- Fair Value
- LOCK|WQ
- Uncertainty
- LOCK|&%
- Economic Moat
- LOCK|G!x?<
- Capital Allocation
- LOCK|>M&<ck
- DGXQuest Diagnostics Inc
Quest Continues to Enjoy a Narrow Moat Thanks to Its Status as Low-Cost Producer
- Rating
- Price
- $242.56
- Fair Value
- LOCK|rz
- Uncertainty
- LOCK|xY!@>
- Economic Moat
- LOCK|TCPQ
- Capital Allocation
- LOCK|<#%%nk
- ZTSZoetis Inc Class A
Reducing Zoetis' Fair Value Estimate in Face of Rising Competition; Wide Moat Remains Intact
- Rating
- Price
- $78.23
- Fair Value
- lr
- Uncertainty
- LOCK|rYP
- Economic Moat
- LOCK|<!
- Capital Allocation
- LOCK|B$qzdYJ
- DEMANTDemant AS
Increase Fair Value Estimate on Strong Product Launch and Improved Sales and Margin Outlook
- Rating
- Price
- DKK 361.20
- Fair Value
- LOCK|Rg
- Uncertainty
- LOCK|@cTN
- Economic Moat
- LOCK|d$^FQ
- Capital Allocation
- LOCK|dX%@X<%
- RHCRamsay Health Care Ltd
We Maintain Ramsay's Narrow Moat Rating on Potential Ramsay Santé Demerger
- Rating
- Price
- A$55.55
- Fair Value
- LOCK|.mz
- Uncertainty
- LOCK|Y#<#
- Economic Moat
- LOCK|?<Z#Z
- Capital Allocation
- LOCK|%Cnr@#
- HUMHumana Inc
Humana's Profit Trajectory Depends on Its Medicare Advantage Prospects
- Rating
- Price
- $414.85
- Fair Value
- jfY
- Uncertainty
- LOCK|@! Q!^lT
- Economic Moat
- LOCK|bdP?Y
- Capital Allocation
- LOCK|&kP!!@
- VTRSViatris Inc
Viatris Looks to New Launches, Pipeline Progression, and Cost Savings for Long-Term Growth
- Rating
- Price
- $18.72
- Fair Value
- >GV
- Uncertainty
- LOCK|y>
- Economic Moat
- LOCK|Cb
- Capital Allocation
- LOCK|^pLMTzH
- BAXBaxter International Inc
Baxter Still Faces High Uncertainty Around Its Turnaround Efforts
- Rating
- Price
- $24.92
- Fair Value
- &H
- Uncertainty
- LOCK|%Mw
- Economic Moat
- LOCK|PP$V$
- Capital Allocation
- LOCK|?F!
Largest Stocks in the Healthcare Sector
|
1-Day Chart
|
Name
|
Industry
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Drug Manufacturers - General | LOCK|PKFp>&# | LOCK|Y^< | $1T | |||
| Johnson & Johnson
JNJ
| Drug Manufacturers - General | LOCK|g!<>f> | LOCK|xBP | $647B | |||
| AbbVie Inc
ABBV
| Drug Manufacturers - General | LOCK|^C?ZS@% | LOCK|qd | $506B | |||
| UnitedHealth Group Inc
UNH
| Healthcare Plans | LOCK|rF^c?Tc | LOCK|^bb!T | $368B | |||
| Merck & Co Inc
MRK
| Drug Manufacturers - General | LOCK|Y&Jnn<Q | LOCK|Pq< | $350B | |||
| Novartis AG ADR
NVS
| Drug Manufacturers - General | LOCK|?!LkpM?^ | LOCK|vh | $294B | |||
| AstraZeneca PLC
AZN
| Drug Manufacturers - General | LOCK|TQt#Vt$ | LOCK|&m | $265B | |||
| Thermo Fisher Scientific Inc
TMO
| Diagnostics & Research | LOCK|M$S><T<< | LOCK|F$ | $256B | |||
| Amgen Inc
AMGN
| Drug Manufacturers - General | LOCK|<@z!^JG$ | LOCK|J%h | $242B | |||
| Gilead Sciences Inc
GILD
| Drug Manufacturers - General | LOCK|!m^vMSD | LOCK|wr | $197B |
More in Healthcare
UnitedHealth Earnings: Margin Improvement Continues in Risk-Taking Operations
We are boosting our near-term expectations on strong trends.
Stock Sector Outlooks: Morningstar’s Top Q4 Picks Across the Market
Morningstar analysts provide their sector outlooks and views on the best stocks to buy.
Healthcare: Stocks Had a Great Q3, as Defensive Nature and Steady Innovation Drew Interest
Medline and BioMarin are among our top stocks in the sector.
33 Undervalued Stocks to Buy Before the Market Shifts Again
Here’s the new list of Morningstar’s top analyst picks for the fourth quarter of 2026.
Weekly Market Update: Stocks Little Changed; Tech Sector Gains While Healthcare Falls
Carnival and Synopsys among the top performers last week.
Aging and Death in America: ‘I Basically Want to Burn It All Down and Restart’
After caring for his sick father, financial planner Elliott Appel has some ideas around health insurance, healthcare spending, and mixed-age communities.
The Best Healthcare Stocks to Buy
These 12 undervalued healthcare stocks look attractive today.
Weekly Market Update: Stocks Flat as Healthcare Rises, Utilities Fall
Ionis Pharmaceuticals, Shake Shack among the worst-performing stocks last week.
The Best Biotech Stocks to Buy
These 5 undervalued biotechnology stocks look attractive today.
Market Wrap: Stocks Fell as Healthcare and Basic Materials Declined
HP, Nokia, and Cloudflare were among the week’s best performers.
United States